TTrialPathMatch Me to Trials
← Back to trials
RecruitingCOPDEmphysema

Bronchoscopic RElease of Air Trapped in Hyperinflated Emphysematous Lung - Study 3

Eligible age

40–84 yrs

Accepts

All genders

Locations

13 states

Healthy volunteers

No

See if you qualify for this study

Answer a few quick questions about your location and health. Takes about a minute.

Check my eligibility →

About this study

The objective of this study is to assess the safety and efficacy of Apreo BREATHE system when used to support native airways and release trapped air in the treatment of adult COPD patients with emphysema suffering from dyspnea due to hyperinflation despite optimal medical treatment. The Apreo BREATHE Airway Scaffold is a permanent implant designed to tent open native airways. The study will include up to 250 participants at up to 25 study centers located in the United States and Europe. Study subjects will be followed for 3 years. The main questions it aims to answer are: Is it safe? Does it work?

Sponsor: Apreo Health, Inc.

Where it's recruiting

Alabama

Birmingham

Arizona

Gilbert

California

Sacramento

Florida

Jacksonville · Orlando

Illinois

Chicago · Peoria

Kansas

Kansas City

Michigan

Ann Arbor

Ohio

Cleveland · Columbus

Pennsylvania

DuBois · Philadelphia · Pittsburgh

Texas

Houston

Virginia

Falls Church

Source: ClinicalTrials.gov · NCT06891755 · last updated 2026-04-24

Bronchoscopic RElease of Air Trapped in Hyperinflated Emphysematous Lu · TrialPath